MIRA INFORM REPORT

 

 

Report Date :           

13.12.2011

 

IDENTIFICATION DETAILS

 

Name :

R.A.K. PHARMACEUTICALS PVT. LIMITED

 

 

Registered Office :

R A K Tower (10th Floor),  Plot # 1/A, Jasimuddin Avenue, Sector # 3, Uttara, Dhaka-1230

 

 

Country :

Bangladesh

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

29.06.2005

 

 

Com. Reg. No.:

C-57891

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacturer, Exporter & Seller of Pharmaceutical Products 

 

 

No. of Employees :

822 persons

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 50,0000.00

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Bangladesh

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


COMPANY DETAILS

 

Name

R.A.K. Pharmaceuticals Pvt. Limited

Note: The subject operates by this name.

Address

R A K Tower (10th Floor),  Plot # 1/A, Jasimuddin Avenue, Sector # 3, Uttara, Dhaka-1230

Country

Bangladesh

Telephone No

880-2- 8963772, 8958319

Fax No

880-2-8961972

E-Mail

info@rakpharma.com

Website

www.rakpharma.com

Established

June 2005

Commercial Production From

July 2009

Company Registration No

C-57891

Registration date

29th June 2005

Legal Status

Private Limited

Issuing Authority

The Registrar of Joint Stock Companies & Firms, Dhaka

Business Type

Manufacturer, Exporter & Seller

Status

Satisfactory

Payment Behavior

No complaints have been heard regarding payments 

from local suppliers or banks.

 

 

LOCATIONS

 

Head Office

R A K Tower (10th Floor),  Plot # 1/A, Jasimuddin Avenue, Sector # 3, Uttara, Dhaka-1230

Telephone No

880-2- 8963772, 8958319

Fax No

880-2-8961972

E-Mail

info@rakpharma.com / hfa@rakpharma.com

Website

www.rakpharma.com

Location

Owned

Branch

NIL

Factory

Village- Faridpur, PS- Sreepur, Dist- Gazipur, Bangladesh

Factory Telephone No

N/A

Factory Fax No

N/A

Warehouse

Village- Faridpur, PS- Sreepur, Dist- Gazipur, Bangladesh

 

DIRECTORS

 

Name

Dr. Khater Massaad

Designation

Chairman

Nationality

Arabian

 

 

Name

Mr. Syed A. K. Anwaruzzaman

Designation

Managing Director

Nationality

Bangladeshi

 

 

Name

Mr. S.A.K. Ekramuzzaman

Designation

Director

Nationality

Bangladeshi 

 

 

Name

Mr. Mohammad Amir Hossain

Designation

Director

Nationality

Bangladeshi

 

 

Name

Mr. Muzammal Hoque

Designation

Director

Nationality

Bangladeshi

 

 

SHAREHOLDERS

 

Name

RAK Ceramics (Bangladesh) Limited

Share Percentage

55%

Country

Bangladesh

 

 

Name

Sponsor Directors

Share Percentage

45%

Nationality

N/A

 


BUSINESS DETAILS

 

Line of Business

Manufacturer, Exporter & Seller

Items Dealing In

Pharmaceutical Products 

Terms of Purchase

Local: Cash or Credit  (30 days)

Import: Against L/C

Terms of Sale

Local: Cash or Credit (30 days)

Export: Against L/C

Types of customers

Wholesalers, Retailers, End Users

 

 

BANKERS

 

Name

AB Bank Limited

Branch

Principal Branch

Address

Motijheel C/A, Dhaka

SWIFT

N/A

Name

Dutch Bangla Bank Limited

Branch

Uttara Branch

 

 

Auditors

 

Name

K. M . Hussan & company

 

 

FINANCIAL INFORMATION

 

(Amt. In BDT Millions)

Particulars

 

31.03.2011

31.03.2010

31.03.2009

Sales Turnover

580.000

129.350

16.480

 

                                                                                           


 

Information Parted By:

 

Name               : Mr. Abu Ahmed Assad Ullha

Designation     : Manager

Mobile No.       : 880-2-8963772

Date                 : 12.12.2011

 

 

CAPITAL STRUCTURE

 

Authorized Capital

Tk.100 million

Paid Up Capital

Tk.200, 000.00

Each Share Value

Tk.100.00

 

 

EXCHANGE RATE

 

Currency

Unit

Bangladeshi Taka (BDT)

 

Great Britain Pound

1

123.4249

U.S Dollar

1

79.1000

European Euro

1

105.8292

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks

No Found

Debt

No Records Found

Litigation

No Records Found

Performance Defaults

No Records Found

Adverse Press Coverage

No Records Found

Money Laundering

No Records Found

 

 

MAXIMUM RECOMMENDED CREDIT

 

Amount

Based On

US$ 50,0000.00

90 Days  

 

 

GENERAL INFORMATION

 

Employees

822 persons

Office Area (Sq. Ft)

2,500 sq.ft (owned)

Factory Area (Sq. Ft)

5.5 acres of land (owned)

Warehouse Area (Sq. Ft)

5,800 sq.ft. (rented)

Range of Products

4 Tablets

4 Capsules

4 Suspensions

4 Creams

4 Ointments

4 Human Drugs & Medicine

Export Market

4 India

4 Sri Lanka

4 Pakistan

4 Nepal

Raw Materials From

4 USA

4 Germany

4 France

Certifications

NIL

Group Name

4 RAK Group

Subsidiaries / Affiliates

4 RAK Ceramics (Bangladesh) Ltd.

4 RAK Power Pvt. Ltd.

4 Rakeen Development Company (BD) Pvt. Ltd.

4 RAK Paints Pvt. Ltd.

4 RAK-MOSFLY (Bangladesh) Pvt. Ltd.

4 RAK Security & Services (Pvt.) Ltd.

4 RAK Airways

4 RAK Piling Bangladesh Pvt. Ltd.

4 RAK Capital Limited

4 RAK Food & Beverage Pvt. Ltd.

4 Classic Porcelain Pvt. Ltd.

Member

4 Bangladesh Pharmaceuticals  Association, Dhaka

4 Dhaka Chamber of Commerce & Industries, Dhaka

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.42

UK Pound

1

Rs.81.92

Euro

1

Rs.69.94

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.